CDH2 and neoplasm: To further analyse the antitumor effect of si‐HOXA11‐AS, we performed haematoxylin and eosin staining, immunohistochemistry staining with Ki67 and immunofluorescence staining with E‐cadherin and N‐cadherin on tumour samples.